These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7363651)

  • 21. The influence of diflunisal on the pharmacokinetics of oxazepam.
    van Hecken AM; Tjandramaga TB; Verbesselt R; de Schepper PJ
    Br J Clin Pharmacol; 1985 Sep; 20(3):225-34. PubMed ID: 4041343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choline magnesium trisalicylate does not impair platelet aggregation.
    Stuart JJ; Pisko EJ
    Pharmatherapeutica; 1981; 2(8):547-51. PubMed ID: 7255512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemostatic effects of salsalate in normal subjects and patients with hemophilia A.
    Sweeney JD; Hoernig LA
    Thromb Res; 1991 Jan; 61(1):23-7. PubMed ID: 2020937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of diflunisal on platelet function and fecal blood loss.
    Green D; Davies RO; Holmes GI; Kohl H; Lee RB; Reynolds N; Schmid FR; Ts'ao CH
    Pharmacotherapy; 1983; 3(2 Pt 2):65S-69S. PubMed ID: 6344041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet antiaggregatory effect of triflusal in human whole blood.
    de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gallopamil and changes of adenosine diphosphate- and collagen-induced thrombocyte aggregation].
    Költringer P; Langsteger W; Lind P; Pierer G; Reisecker F; Eber O
    Arzneimittelforschung; 1991 Aug; 41(8):786-8. PubMed ID: 1781797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Diflunisal on Platelet Function and Fecal Blood Loss.
    Green D; Davies RO; Holmes GI; Kohl H; Lee RB; Reynolds N; Schmid FR; Ts'ao CH
    Pharmacotherapy; 1983 Mar; 3(2 Pt 2):65S-69S. PubMed ID: 29112307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diflunisal protects human gastric mucosa against damage by indomethacin.
    Cohen MM
    Dig Dis Sci; 1983 Dec; 28(12):1070-7. PubMed ID: 6581036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of diflunisal on the steady state pharmacodynamics and pharmacokinetics of warfarin [proceedings].
    Serlin MJ; Mossman S; Sibeon RG; Breckenridge AM
    Br J Clin Pharmacol; 1980 Mar; 9(3):287P-288P. PubMed ID: 7362744
    [No Abstract]   [Full Text] [Related]  

  • 31. Collagen-induced platelet aggregation:--evidence against the essential role of platelet adenosine diphosphate.
    Nunn B
    Thromb Haemost; 1979 Dec; 42(4):1193-206. PubMed ID: 542929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diflunisal ('Dolobid') once-a-day in the treatment of rheumatoid arthritis.
    Bocanegra TS; Dicenta C; Carpignano M; Neu DC; Bolognese JA
    Curr Med Res Opin; 1985; 9(8):568-77. PubMed ID: 3161703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Farmaco Sci; 1986 Mar; 41(3):205-14. PubMed ID: 3086120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet aggregation in neonates with hyperbilirubinaemia.
    Hiçsönmez G; Prozorova-Zamani V
    Scand J Haematol; 1980 Jan; 24(1):67-70. PubMed ID: 7367834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of diflunisal on hyaluronic acid production by 'activated' human synovial fibroblasts.
    Yaron M; Yaron I
    Br J Clin Pharmacol; 1981 Sep; 12(3):423-6. PubMed ID: 7295473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of triflusal on platelet activation after coronary artery bypass graft.
    Prieto MA; De La Cruz JP; Del Prado MF; Sánchez de la Cuesta F
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):191-7. PubMed ID: 10759013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cefonicid on platelet aggregation.
    Cazzola M; Santangelo G; Paizis G; Matera C; Rossi F
    Drugs Exp Clin Res; 1991; 17(2):105-8. PubMed ID: 1864223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of inhibition of mitochondrial oxidative phosphorylation by the nonsteroidal anti-inflammatory agent diflunisal.
    McDougall P; Markham A; Cameron I; Sweetman AJ
    Biochem Pharmacol; 1983 Sep; 32(17):2595-8. PubMed ID: 6225435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.
    Abumiya T; Houkin K
    J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.